Medtronic, unfortunately, is now stuck with a nearly $221 million tax dispute with the Internal Revenue Service as a result of buying Covidien last year. It has now agreed to settle, according to a regulatory filing.
Back in 2013, Covidien’s corporate predecessors, Tyco International and TE Connectivity, were told by the IRS that they owed $914 million to the U.S. Treasury – plus another $154 million in penalties – based on illegitimate deductions that were reported.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
So now, this debt must be split up, and Medtronic is getting the majority of the blow.
The total amount was reportedly negotiated down to between $475 million and $525 million. Medtronic owes 42 percent of that – somewhere between $199.5 million and $220.5 million. Tyco will take on 27 percent of the debt ($128.3 million to $141.8 million) and TE Connectivity is responsible for 31 percent $147.3 million to $162.8.
Although this payment doesn’t really put a dent in Medtronic’s finances overall, it’s perhaps a reminder to be clear on all accounts of what a company is buying into with M&A transactions.
According to the filing, the Tax Sharing Participants expect payment to be made to the IRS and among the parties within the next six months.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Photo: Flickr user Rocky Lubbers
